Literature DB >> 16214393

The role of oxidative stress in NASH and fatty liver model.

Isao Sakaida1, Kiwamu Okita.   

Abstract

The aim of this study was to investigate whether oxidative stress is related to the development of liver injury and an iron chelator, deferoxamine (DFO) can prevent lipid peroxidation resulting in reduced liver injury as well as reduce preneoplastic lesions induced by a choline-deficient l-amino acid-defined (CDAA) diet. CDAA diet administration resulted in an increased serum ALT level after one week. Hepatocytes in rat liver fed a CDAA diet showed malondialdehyde (MDA) accumulation. But simultaneous DFO treatment for one week reduced this elevation of ALT as well as MDA accumulation in the liver. Feeding rats a CDAA diet for 14 weeks led to the development of severe liver fibrosis and preneoplastic lesions detected as enzyme-altered lesions. DFO treatment also prevented the expression of activated stellate cells, resulting in the reduction of liver fibrosis as well as reducing the development of preneoplastic lesions. These results indicate that iron chelation can reduce the development of preneoplastic lesions in a CDAA diet model.

Entities:  

Year:  2005        PMID: 16214393     DOI: 10.1016/j.hepres.2005.09.019

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  13 in total

1.  The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis.

Authors:  Haiyan Jin; Shuji Terai; Isao Sakaida
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  J Nutr Biochem       Date:  2016-09-22       Impact factor: 6.048

3.  Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver.

Authors:  Paola Dongiovanni; Luca Valenti; Anna Ludovica Fracanzani; Stefano Gatti; Gaetano Cairo; Silvia Fargion
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 4.  Autoimmune features in metabolic liver disease: a single-center experience and review of the literature.

Authors:  Koichi Tsuneyama; Hayato Baba; Kentaro Kikuchi; Takeshi Nishida; Kazuhiro Nomoto; Shinichi Hayashi; Shigeharu Miwa; Takahiko Nakajima; Yuko Nakanishi; Shinji Masuda; Mitsuhiro Terada; Johji Imura; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

5.  Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats.

Authors:  Koji Fujita; Masato Yoneda; Koichiro Wada; Hironori Mawatari; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Shiro Maeyama; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Atsushi Nakajima
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

Review 6.  Non-alcoholic fatty liver disease and the risk of urolithiasis: A systematic review and meta-analysis.

Authors:  Shaoyou Qin; Song Wang; Xu Wang; Jiangbin Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function.

Authors:  Hossein Rafiei; Kosar Omidian; Brian Bandy
Journal:  Nutrients       Date:  2019-03-03       Impact factor: 5.717

8.  Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study.

Authors:  Aein Azarang; Omid Farshad; Mohammad Mehdi Ommati; Akram Jamshidzadeh; Reza Heydari; Seyedeh Narjes Abootalebi; Ahmad Gholami
Journal:  Biomed Res Int       Date:  2020-11-06       Impact factor: 3.411

Review 9.  Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease.

Authors:  Ayokanmi Ore; Oluseyi Adeboye Akinloye
Journal:  Medicina (Kaunas)       Date:  2019-01-24       Impact factor: 2.430

10.  Korean Red Ginseng and Korean black ginseng extracts, JP5 and BG1, prevent hepatic oxidative stress and inflammation induced by environmental heat stress.

Authors:  Ji-Hyeon Song; Kui-Jin Kim; Sungwoo Chei; Young-Jin Seo; Kippeum Lee; Boo-Yong Lee
Journal:  J Ginseng Res       Date:  2018-12-16       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.